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  ABSTRACT 
 
 
The Carbon Reduction Benefits on Health (CaRBonH) calculation tool allows quantification of the physical and 
economic consequences for human health achieved through improvements in country-level air quality from 
domestic carbon reductions, specifically policy mitigation actions and measures as reported in the NDCs 
submitted by the Conference of the Parties to the UNFCCC in support of the objectives as set out in Article 2 of 
the Convention. 
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(Intended) nationally determined contributions and the Paris Agreement 
The United Nations Framework Convention on Climate Change  
The United Nations Framework Convention on Climate Change (UNFCCC), which was adopted at the 
United Nations Conference on Environment and Development held in Rio de Janeiro in June 1992, entered 
into force on 21 March 1994 (1). At the Conference, the world community came together and 
acknowledged the long-term negative environmental consequences associated with rapidly increasing 
anthropogenic emissions of climate-altering pollutants. Country delegates reached a consensus on the 
urgency for coordinated, comprehensive actions at all levels of society – local, national, regional and 
global – to meaningfully mitigate future emissions as well as adapt to climate variability and long-term 
change. Contingency and adaptation interventions are meant to curb the most adverse effects of climate 
change on the natural and built environments, ecosystems and health systems, and act to limit community 
exposure and related climate risks, including health burdens, and the potential for population 
displacement and increased social conflicts. 
Among the specific goals set by the UNFCCC, Article 2 reads as follows (1). 
The ultimate objective of this Convention and any related legal instruments that the Conference of the Parties 
may adopt is to achieve, in accordance with the relevant provisions of the Convention, stabilization of 
greenhouse gas concentrations in the atmosphere at a level that would prevent dangerous anthropogenic 
interference with the climate system. Such a level should be achieved within a time frame sufficient to allow 
ecosystems to adapt naturally to climate change, to ensure that food production is not threatened and to 
enable economic development to proceed in a sustainable manner.  
In addition, industrialized nations: 
 committed themselves to lead efforts to limit climate-altering pollutants emissions (Annex I); 
 agreed to provide technical assistance, share technology with poorer countries and establish 
financial mechanisms in support of actions against climate change; and 
 established a routine accounting and reporting framework for the implementation of national 
climate change mitigation policies and measures, tracking of emissions inventory and consideration 
of arrangements for adaption (manage the unavoidable). 
Sustainable human development may be defined as living in a world where consumption demands less of 
the ecosystem services that the earth can deliver without compromising the needs of future generations. 
Economic and social development requires a holistic approach underpinned by sound economic analysis 
that also promotes environmental protection while enabling all peoples to share equally in the 
opportunities and benefits of social development regardless of social or economic status and gender. The 
risks of different economic development strategies therefore need to be assessed and the results 
communicated to decision-makers and the general public in a transparent and concise way that takes 
account of socioeconomic trade-offs and uncertainties on present and future generations. 
The Paris Agreement on Climate Change  
In 2011, the United Nations Climate Change Conference of Parties (COP17) established the Durban 
Platform with the goal of adopting a legally binding instrument by 2015 in which all Parties would commit 
themselves to domestic action to mitigate greenhouse gas emissions beyond 2020 in an effort to stabilize 
ambient concentrations and prevent global mean surface temperature change from exceeding a 
threshold of 2 ℃ by the end of the 21st century. Furthermore, countries would attempt to make additional 
efforts to limit ambient temperatures to below 1.5 ℃ (Fig. 1). The IPCC SR1.5 report1 forms an official 
collection of all known scientific, peer-reviewed, research on the impacts of 1.5°C of global warming on 
natural and human systems around the world. 
                                                          
1  www.ipcc.ch/report/sr15/ 
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Fig. 1. Global temperature changes and issues for concern due to increasing levels of climate change 
 
 
Source: Intergovernmental Panel on Climate Change (2). 
 
 
The Paris Agreement, which was adopted by delegates to the Conference of Parties of the UNFCCC in Paris 
in 2015 (COP21) (3), reflects a changing landscape in international climate policy with renewed emphasis 
on mitigating greenhouse gas emissions and preparing for and managing the current and projected 
consequences of a changing climate (adaptation). The Agreement formalized countries’ commitments to 
achieve climate-related policy goals/targets through their nationally determined contributions (NDCs). 
The Agreement went into effect on 4 November 2016; by November 2017 it had been signed by 195 
parties and ratified by 170 countries, collectively representing 87.9% of global industrialized emissions.  
Linking carbon reductions to health benefits 
The Paris Agreement represents an opportunity and a challenge for nations to promote policy-making and 
social awareness of the co-benefits on health from reducing emissions of health-damaging pollutants 
through implementation of climate-friendly policies and adaptation action, as outlined in the 
communications relating to their pledged NDCs (4). 
Thus, it is worth examining which consequential environmental and health benefits have been achieved 
through reductions in domestic carbon emissions for the proposed climate policies under the NDCs 
submitted by Member States of the WHO European Region to the UNFCCC. 
To answer this question, an Excel-based tool has been developed for the 53 Member States in the Region 
that quantifies the health and related economic gains from implementation of the NDCs. Such a tool can 
be used as a mechanism to assess the outcome of climate-driven policies and to promote decision-making 
in settings where there is limited data availability. 
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Overview of the Carbon Reduction Benefits on Health (CaRBonH) calculation tool 
Scope of the tool 
The aim of the Carbon Reduction Benefits on Health (CaRBonH) calculation tool is to quantify the physical 
and economic consequences for human health achieved through improvements in country-level air 
quality from domestic carbon reductions, specifically policy mitigation actions and measures as reported 
in the NDCs submitted by the Conference of the Parties to the UNFCCC in support of the objectives as set 
out in Article 2 of the Convention. 
Description of the tool 
A flowchart of the tool is presented in Fig. 2. The Excel workbook consists of nine worksheets, covering: 
(i) user input on pollutant emission reductions from carbon mitigation interventions by country 
(worksheet Emission reductions); 
(ii) endogenous calculations of changes in population exposure from saved emissions; 
(iii) calculation of health benefits in the susceptible population in terms of reduced incidences of annual 
morbidity, postponed mortality (deaths) and gains in years of life expectancy, together with an 
economic valuation of health benefits achieved from carbon reductions (worksheet Summary of 
results); and  
(iv) two worksheets with preloaded default statistics on demographic and epidemiological data by 
country for 2010, 2020 and 2030.  
 
Health hazards are calculated using an impact pathway analysis, which explicitly traces the fate of 
pollutants from the moment they are released into the environment, followed by atmospheric dispersion 
and eventual removal by deposition and chemical transformation (Fig. 3). Health outcomes are calculated 
using epidemiological associations (risk functions that link population response to changes in ambient 
exposure level). The health benefits of reduced air pollution are transformed into economic costs using 
unit health costs, that is, cost per case of disease or death. Unit costs combine both market and non-
market elements in determining an equivalent monetary value that accounts for direct impacts on the 
gross domestic product (GDP) of a nation, and indirect impacts on social welfare due to pain and suffering 
while someone is ill. 
User input 
Reductions in emissions of greenhouse gases and other pollutants, including primary particulate matter 
(PPM) of aerodynamic diameter less than 2.5 μm,2 sulfur dioxide (SO2), nitrogen oxides (NOx), and 
ammonia (NH3) are entered in the worksheet Emission reductions (Fig. 4, 5). Input is differentiated by 
emitter country for 2020 and 2030 (users may enter information for either or both years). GHG reductions 
are specified with respect to a particular base year, while reductions of other pollutants are compared 
against a business as usual emissions scenario. The Region is divided into 22 subdivisions, including 
countries belonging to the European Union (EU) after July 2013 (EU28),3 Belarus, Israel, the Republic of 
Moldova, the Russian Federation, Turkey, Ukraine and eastern European and central Asian countries. Data 
may be entered for a single country/region or for a group of countries (for example, Annex I countries 
only). Emission reductions by pollutant type for Andorra, Monaco and San Marino are added to EU28 
values. For this block of countries, the tool calculates a single estimate of PM2.5 exposure change, health 
gains and economic benefits. When only PM10 emissions data are available, PM2.5 to PM10 mass conversion 
factors may be applied to estimate changes in PM2.5 emissions. These conversion factors vary by country; 
default values have been summarized in the worksheet Effect PPM reduction on PM2.5. Other than 
emission reductions, the tool requires no additional input from the user. 
                                                          
2 1 μm = one-millionth (10−6) of a metre, or micron. 
3 Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, 
Slovenia, Spain, Sweden and the United Kingdom of Great Britain and Northern Ireland. 
  
 
Fig. 2. Carbon Reduction Benefits on Health (CaRBonH) software tool at a glance 
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Fig. 3. Methodological framework implemented in the CaRBonH calculation tool 
 
 
 
Tool output – exposure calculations 
Changes in PM2.5 concentrations due to reductions in domestic and regional PM2.5, SO2, NOx and NH3 
emissions are provided in the four worksheets Effect xxx reduction on PM2.5, where xxx stands for PPM, 
SO2, NOx and NH3. Country-to-country blame matrices, also known as source-receptor tables, are used to 
calculate population exposure changes. These matrices are look-up tables used to calculate concentration 
changes in a receptor (receiving) country due to domestic emission reductions as well as attributions from 
emissions changes in neighbouring emitter (polluter) countries that feed into transboundary pollution at the 
regional level (Table 1). These data have been calculated by the European Monitoring and Evaluation 
Programme of the European Commission (5), and have been supplemented with further calculations carried 
out with the uniform world model developed by Spadaro (6). The contribution to the total change in ambient 
PM2.5 concentrations from decreases in national and regional emissions is shown in Fig. 6 Country-specific 
modifier factors (Table 2) are used to compute changes in population-weighted exposures, starting with 
geographically averaged concentrations (Table 3, 4). The modifier factors are summarized by country in the 
worksheet Effect PPM reduction on PM2.5. 
Tool output – health gains and economic benefit calculations 
Output results are summarized in tables and shown graphically in the worksheet Summary of results. In 
addition to summarizing user input information and other country statistics, this worksheet shows the 
health and economic co-benefits of carbon mitigation interventions that may be achieved through 
improvements in air quality as a result of reductions in air pollutant emissions. CaRBonH apportions the 
results according to reductions in national emissions plus additional health benefits achieved from 
emission reductions that occur in other countries – the transboundary pollution effect (Fig. 7). Susceptible 
population subgroups, such as children and sick and elderly people, who are exposed to atmospheric 
contaminants are at a higher risk of suffering from adverse health symptoms ranging from mild discomfort 
to more serious life-threatening conditions. The quantified health benefits of reduced emissions include 
prevented cases of illness (morbidity), fewer premature deaths and life years gained from an extension in 
life expectancy among the exposed population (Table 5, Fig. 8).  
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Fig. 4. Air emissions avoided from implementation of NDC carbon reductions in 2030 
 
                          
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Notes. 
  Reductions in greenhouse gas emissions are based on NDC pledges and historical data from the UNFCCC 
(Table 13). Negative values indicate an increase in emissions over the base year. NDC targets are typically 
specified relative to a base year (1990 in this example) compared to a future baseline (in this example, 2030 
for Israel) or in terms of reduced carbon intensity (greenhouse gas emissions per unit of GDP, for example, in 
the case of Uzbekistan). 
  For the other pollutants, emissions avoided in 2030 are estimated using published results by the Greenhouse 
gas – air pollution interactions and synergies Europe model (15). The model identifies synergies and trade-
offs from limiting local and regional air pollution and mitigation of greenhouse gas emissions. 
  By 2030, the proposed policies would reduce emissions of PM2.5 by 17%, SO2 by 25%, and NOx by 13% from 
1990 levels. 
A copy of the WHO policy brief is available (11). 
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Fig. 5. Reduced emissions (mega-tonnes of carbon dioxide (CO2) equivalent) of the greenhouse gases shown in Fig. 
4, and relative changes in 2030 compared to 1990 levels (net emission reduction 2966 metric tons CO2 equivalent) 
 
Rest of countries = remaining countries shown in Fig. 4 
 
Note. The chart shows the absolute and relative changes from implementation of proposed NDC pledges. Most 
countries have set targets to reduce carbon emissions below 1990 levels, while others (such as Turkey) have set 
emission caps or intend to reduce future emission growth rates relative to a business as usual scenario. Further 
reductions could be achieved through international cooperation, knowledge sharing and financial support. 
 
 
Table 1. Example of a source-receptor table for changes in PPM (PM10) emissions 
 
 
Source: European Modelling and Evaluation Programme (EMEP) (5). 
 
Note. Interpretation of table entries: change in background concentrations of PM2.5 (ng/m3) in receiver country (row) 
due to a specified reduction in emissions of PPM (PM10) in emitter country (column). 
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Fig. 6. PM2.5 change (ng/m3) for a uniform 15% reduction of PM10 and SO2 emissions in EU28 countries 
 
Source: EMEP (5). 
 
 
Note. Cuts in SO2 emissions contribute to lower concentrations of sulfates, a secondary chemically derived 
component of PM2.5, which have a stronger regional impact than reductions in emissions of primary PM. 
 
Health effects are calculated using the WHO Health risks of air pollution in Europe – HRAPIE project set of 
recommended relative risks for Europe (7), which cover bronchitis and asthma attacks in children, chronic 
bronchitis and work lost days (WLD) in adults, and other illnesses that affect a person's normal daily 
routine (in other words, restricted activity days), or worse yet may require hospital admission because of 
cardiopulmonary system complications. The relative risk is defined as the ratio of health hazards for two 
populations exposed to different levels of pollution. These coefficients are determined through 
epidemiological studies, and relate an exposure increment to an increase in the prevalence of illness or 
baseline mortality in the population of concern. Relative risks are transformed into concentration–
response functions (CRF) – the annual burden per person and per unit concentration – using country-
specific data such as illness or mortality baseline rate and share of the population affected by the health 
outcome of concern (Fig. 9). Since demographic data vary by year, so do the CRFs. 
Finally, an economic value is put on health benefits (Table 6, Fig. 10), taking into consideration the health 
care expenditure and productivity losses (market costs) prevented plus the social costs (welfare benefit) 
attributed to premature deaths averted or life-years gained (8). Postponed mortality is valued using the 
value of statistical life, the price that society is willing to pay to prevent an anonymous (statistical) death, 
while life extension is valued using the value of a life-year. Mortality benefits are not market costs; instead 
the economic benefits represent a gain in social well-being from reduced pain and suffering caused by 
environmental stressors such as air pollution. Morbidity costs are market expenditures (included in the 
transaction costs of doing business), and have a direct consequence on the country's GDP. At the level of 
the citizen, illness has direct consequences on the quality of life and indirect consequences on personal 
income and savings. 
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Table 2. Parameters used in CaRBonH for calculations of changes in population exposure in Table 3 
 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software (worksheet Effect PPM reduction on PM2.5). 
 
  
 
Table 3. PM2.5 exposure change (ng/m3) from reduced PM2.5 emissions shown in Fig. 4 
 
 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑤𝑒𝑖𝑔ℎ𝑡𝑒𝑑
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑐ℎ𝑎𝑛𝑔𝑒 ∆𝐶
𝑖𝑛 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟 𝑐𝑜𝑢𝑛𝑡𝑟𝑦
 = ∆𝐶 
(𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟) 𝑝𝑒𝑟
𝑘𝑡 𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛 (𝑒𝑚𝑖𝑡𝑡𝑒𝑟)  ×  
𝐸𝑚𝑖𝑠𝑠𝑖𝑜𝑛𝑠
𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 (𝑒𝑚𝑖𝑡𝑡𝑒𝑟)  ×  
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑚𝑢𝑙𝑡𝑖𝑝𝑙𝑖𝑒𝑟
𝑓𝑎𝑐𝑡𝑜𝑟 (𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟)  
 
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑟
𝑓𝑎𝑐𝑡𝑜𝑟  =  
௎௥௕௔௡ ௟௘௩௘௟ ௣௢௣௨௟௔௧௜௢௡
௪௘௜௚௛௧௘ௗ ௖௢௡௖௘௡௧௥௔௧௜௢௡
்௢௧௔௟ ௖௢௡௖௘௡௧௥௔௧௜௢௡
௖௛௔௡௚  ∆஼ ௜௡ ௖௢௨௡௧௥௬
 × 𝐴𝑛𝑡ℎ𝑟𝑜𝑝𝑜𝑔𝑒𝑛𝑖𝑐
𝑠ℎ𝑎𝑟𝑒
     and    𝑇𝑜𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛𝑐ℎ𝑎𝑛𝑔𝑒 ∆𝐶 𝑖𝑛 𝑐𝑜𝑢𝑛𝑡𝑟𝑦 =  
∆஼ (ఓ௚/௠య) ௗ௨௘ ௧௢ ௡௔௧௜௢௡௔௟ ௘௠௜௦௦௜௢௡ ௥௘ௗ௨௖௧௜௢௡௦
ௌ௛௔௥௘ ௢௙ ∆஼ ௔௧௧௥௜௕௨௧௘ௗ ௧௢ ௡௔௧௜௢௡௔௟ ௘௠௜௦௦௜௢௡ ௥௘ௗ௨௖௧௜௢௡௦
 
Note. EMEP spatially averaged country-level concentrations are transformed to population-weighted values using a country modifier factor (Table 2), which is calculated 
dividing the urban-level population-weighted mean concentration (16) by the total change in country concentration ∆C if ALL pollutant emissions from both national sources 
plus contributions from neighbouring countries in EMEP are reduced to zero. Finally, the modifier is multiplied by the anthropogenic contribution to ambient concentration. 
The total concentration change is the ratio of the attributable change due to national emission reductions and the share that these emission changes make to the total 
country-level concentration (see Fig. 6). The proportion contributed by national emissions is calculated using the EMEP country-to-country blame matrix (diagonal element 
divided by the sum of values along a row for a given receptor country or the EU28). 
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Table 4. Reduced population-weighted exposure in 2030 for emission reduction shown in Fig. 4 
 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
 
 
Note. Greenhouse gas changes are relative to base year 1990. For other pollutants, the changes are relative to the 
2030 business as usual scenario. 
 
The user can navigate to different areas in the Summary of results worksheet using the Jump to box 
located at the top right corner of the worksheet (options include: view comments, review 2020 or 2030 
summary tables, and go to the figures). The user has access to all the output results and interim 
calculations (for example, tables of concentration changes in the four worksheets Effect xxx reduction on 
PM2.5) and may use this information to prepare additional summary tables and graphs. 
Software preloaded databases 
The following worksheets contain default data and background information, which can be modified or 
supplemented by the user: 
 Exposure costs: contains epidemiological data, illness and mortality costs for the 53 Member States 
for 2010, 2020 and 2030 (Fig. 11); 
 Demographics: contains demographic data by country for 2010 plus projections for 2020 and 2030 
according to published data by (9). 
 manual: Health benefits of carbon reductions (this document). 
 
 
 
 
Change due to 
domestic emission 
reductions 
Combined effect of 
national and 
regional reductions 
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Fig. 7. Air quality and economic benefits from domestic and regional emission cuts as shown in Fig. 4 
 
 
 
 
 
 
 
 
 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
 
 
 
Note. There are significant environmental, health and economic benefits to be achieved from concerted regional 
efforts to limit carbon emissions, leading to win−win opportuniƟes across all Member States. 
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Additional resources 
The following additional resources are available. 
 Achieving health benefits from carbon reductions − Role of (intended) nationally determined 
contributions. PowerPoint presentation, including a validation exercise (10). 
 WHO Policy Brief: Healthy mitigation in the WHO European Region. An application of the CaRBonH 
calculation tool (11). 
 Background on the UNFCCC: The international response to climate change (12). 
 Climate Action Tracker (13). 
 CAIT Climate Data Explorer (14). 
 
Table 5. Averted morbidity and mortality from reductions in PM2.5 ambient concentrations in 2030 
 
WLD = work lost days; RAD = restricted activity days; HA = hospital admissions; YLL = years of life lost. 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
 
Notes. 
 Implementation of NDC pledges with corresponding emission reductions shown in Fig. 4 lead to 74 000 
premature deaths or 736 000 life-years gained annually. For the population alive in 2030, the reduced 
mortality risk is equivalent to an increase in life expectancy of around half a month (approximately 11 days 
gained per decrement of 1 μg/m3 of PM2.5). 
 Equation for calculating health benefits (applied individually to each country or region and health outcome): 
Health
benefit  =  
PMଶ.ହ concentration
change  ×  
Country
population  ×  
Concentration– response
function  
 Default data on population (worksheet Demographics) and concentration–response functions (worksheet 
Exposure costs) are summarized in the preloaded databases. 
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Fig. 8. Averted annual mortality (prevented premature deaths) (thousands) from implementation 
of NDC pledges in the 53 Member States in 2030 for emission cuts shown in Fig. 4 
 
Russia = Russian Federation; Moldova = Republic of Moldova. 
Caucasus = Armenia, Azerbaijan, Georgia. 
Central Asia = Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan. 
EU28 = Austria, Belgium, Bulgaria, Croatia, Czech Republic, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, 
Ireland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Malta, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, 
United Kingdom. 
EFTA (European Free Trade Association) = Iceland, Norway, Switzerland. 
Balkans = Albania, Bosnia and Herzegovina, Montenegro, Serbia, the former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
 
Notes. 
 The preventable mortality from reduced air pollutant emissions in 2030 is 74 000 deaths, of which 45 100 
(61%) of total deaths are averted across EU member states. This figure represents around 10% of the health 
burden attributed to ambient air PM pollution in 2010. The health benefit in the Russian Federation equals 
12 700 (or 17%) of avoidable deaths. The magnitude of these values is closely related to the exposed 
population size: the EU28 contribute 55% of the total exposed population, followed by the Russian Federation 
with 15%. In terms of years of life expectancy gained, the total benefit across Region is 736 000 life-years 
gained, of which 55% is attributed to EU28 countries. 
 In addition to prevented mortality, improved air quality results in fewer cases of illnesses (morbidity), 
including 49 000 fewer hospital admissions, 1.9 million fewer incidences of asthma attacks and 350 000 
prevented cases of bronchitis in children, 50 000 fewer cases of chronic bronchitis in adults and nearly 83 
million restricted activity days averted plus an additional 17 million work lost days (Table 5). 
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Fig. 9. PM2.5 CRF used in the CaRBonH calculation tool (2010) 
 
WLD = work lost days; RAD = restricted activity days; YLL = years of life lost. 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: preloaded database in CaRBonH software (worksheet Exposure costs). 
 
Notes. 
 CRFs have units: excess (additional) annual cases of illness (morbidity) or premature mortality (expressed as 
number of deaths or years of life lost) per person and for an incremental change in ambient PM2.5 
concentration of 1 μg/m3. 
 CRFs are linear, meaning there is a constant change in health risk for the same increase in exposure over the 
entire range of plausible concentrations. In addition, it is assumed that exposure functions do not have a 
threshold below which there are no ill effects in the vulnerable population. Thus, 
annual burden for a specific health endpoint = ambient concentration increase × exposed population 
× CRF for that illness. 
 CRFs are calculated using the following expressions (17) (it is assumed that everyone in a country is exposed 
at the weighted mean concentration): 
𝐶𝑅𝐹 =  ൬
𝑅𝑅 − 1
𝑅𝑅
൰ ൬
1
∆𝐶
൰ ∙ 𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒𝑟𝑎𝑡𝑒 ∙ 𝑓௣௢௣ 
𝐶𝑅𝐹 (𝑙𝑖𝑓𝑒 𝑦𝑒𝑎𝑟𝑠 𝑙𝑜𝑠𝑡, 𝑌𝐿𝐿) = 𝐸𝑥𝑝(8.161 − 0.04478 ∙ 𝐿𝐸) ∙ 𝑓௣௢௣,ଷ଴ା ∙ 10ିହ 
where relative risks is the relative risk of the health outcome in question (7), prevalence rate is the number 
of cases of illness per year (or mortality rate) per person in the population at risk of illness, ∆C is the change 
in PM2.5 population-weighted concentration in units of μg/m3, fpop is the share of the total population 
affected by the health outcome of concern (age group), fpop,30+ is the group aged 30 years and older and LE 
is life expectancy at birth (both sexes). 
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Table 6. Economic benefits from reduced PM2.5 emissions in 2003 (US$ million, 2005 prices) 
 
WLD = work lost days; RAD = restricted activity days; HA = hospital admissions; YLL = years of life lost. 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: CaRBonH software. 
 
Notes. 
 The economic cost of prevented illnesses and mortality in 2030 is US$ 277 billion (2005 prices) if valuing 
postponed premature deaths (or US$ 97 billion if valuing life-years gained). Put another way, these results 
represent between 0.5% and 1.2% of the annual GDP of the 53 Member States. The EU28 contribution is 64% 
(or 75% if valuing mortality as life-years gained). The prevented health morbidity alone contributes about US$ 
19 billion (Fig. 4).  
 Equations for calculating economic benefits (applied individually to each country or region and health 
outcome): 
𝑒𝑐𝑜𝑛𝑜𝑚𝑖𝑐
𝑏𝑒𝑛𝑒𝑓𝑖𝑡 =  
𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒  ×  
𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒
𝑐𝑜𝑠𝑡      and    
𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒
𝑐𝑜𝑠𝑡 = 𝐶𝑅𝐹 ×  
𝑐𝑜𝑠𝑡 𝑝𝑒𝑟 𝑐𝑎𝑠𝑒 𝑜𝑓 𝑖𝑙𝑙𝑛𝑒𝑠𝑠
(𝑜𝑟 𝑑𝑒𝑎𝑡ℎ, 𝑦𝑒𝑎𝑟𝑠 𝑜𝑓 𝑙𝑖𝑓𝑒 𝑙𝑜𝑠𝑡) 
Default data on exposure costs are summarized in the worksheet Exposure costs. 
 Morbidity costs are market expenditures (included in the transaction costs of doing business); they have a 
direct consequence on a country’s GDP and, at the level of the citizen, impact the quality of life and indirectly 
affect personal income and savings. Mortality benefits are not market costs; instead the economic benefits 
represent a gain in social well-being, or welfare, from reduced pain and suffering associated with air pollution 
as a risk factor. 
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Fig. 10. Morbidity benefits from implementation of NDC pledges for emission reductions shown in Fig. 4 
 
Source: CaRBonH software.  
 
 
Fig. 11. Costs of illness and mortality for selected countries (US$ per case at 2005 prices, undiscounted) 
 
Source: preloaded database in CaRBonH software (worksheet Exposure costs). 
 
Notes. 
 Health outcomes. Children: bronchitis (6–12 years); asthma symptom days (5–19 years). Adults: new cases of 
chronic bronchitis (27+ years); work lost days due to absenteeism (labour force aged 18–64 years). All ages: 
restricted activity days; hospital admissions; mortality (valuation based on the value of statistical life applied 
to number of deaths, or the value of a life-year applied to loss of life expectancy). 
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 Cost adjustment from country A to country B (benefit transfer method). Ideally, national or regional studies 
should be used to value local economic losses due to air pollution. In the absence of such data, however, the 
equation below may be used to transfer unit health costs from another site (study) to the current location 
(18).The adjustment takes into account differences in income levels between the two places, with all other 
socioeconomic conditions assumed to be similar. Here, Y is the GDP per capita (at purchasing power parity 
prices), and β is an income elasticity factor, whose values are 0.8, 0.9 and 1.0, respectively, for high, upper 
middle and lower middle-income countries (8). 
𝐶𝑜𝑠𝑡஼௢௨௡௧௥௬ ஻ = 𝐶𝑜𝑠𝑡஼௢௨௡௧௥௬ ஺ ∙ ቆ
𝑌஼௢௨௡௧௥௬ ஻
𝑌஼௢௨௡௧௥௬ ஺
ቇ
ఉ
 
 Cost adjustment over time (income growth effect). Future costs are calculated using the following expression, 
where tref and t represent, respectively, the reference and future times. Future GDP/capita growth is based 
on the real income growth rate (constant currency, no inflation). Often, the elasticity of marginal utility of 
consumption δ is assumed to be equal to the income elasticity β. 
𝐶𝑜𝑠𝑡(𝑡) = 𝐶𝑜𝑠𝑡൫𝑡௥௘௙൯ ∙ ቆ
𝑌௧
𝑌௧ೝ೐೑
ቇ
ఋ
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Annex 1. Historical emissions of aggregate greenhouse gases in CO2 equivalent 
metric tons (without land use, land use change and forestry) 
 
Country/Region 1990 2000 2010 2015 
Albania 4.34 5.78 8.13 (2009)  
Andorra No data 
Armenia 25.00 5.53 7.20  
Azerbaijan 73.40 40.60 48.00 51.80 (2012) 
Belarus 137.00 81.30 93.90 89.60 
Bosnia and Herzegovina 34.00 15.20 28.00 31.10 (2011) 
Georgia 38.70 10.60 12.90 16.60 (2013) 
Iceland 3.54 3.87 4.65 4.54 
Israel  67.20 77.30 78.60 (2013) 
Kazakhstan 389.00 193.00 309.00 301.00 
Kyrgyzstan 28.40 9.28 12.80  
Monaco 0.10 0.11 0.09 0.08 
Montenegro 5.71 5.61 4.02 3.86 (2011) 
Norway 51.70 54.60 55.20 53.90 
Republic of Moldova 43.40    
Russian Federation 3768.00 2273.00 2601.00 2651.00 
San Marino   0.27  
Serbia 80.80 66.30 (1998)   
Switzerland 53.40 52.40 54.40 48.00 
Tajikistan 24.20 6.75 8.18  
The FYR of Macedonia 13.30 12.10 11.50 (2009)  
Turkey 214.00 296.00 407.00 475.00 
Turkmenistan  50.30 66.40  
Ukraine 962.00 427.00 413.00 323.00 
Uzbekistan 180.00 198.00 199.00 205.00 (2012) 
EU 5643.00 5152.00 4775.00 4308.00 
The FYR of Macedonia = The former Yugoslav Republic of Macedonia. 
Source: Greenhouse gas inventory data – detailed data by party [online database]. Bonn: United Nations Framework 
Convention on Climate Change; 2018 (http://di.unfccc.int/detailed_data_by_party, accessed 23 June 2018). 
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